Objective: Transcutaneous bilirubinometers are useful in screening and monitoring neonatal hyperbilirubinemia. These instruments reduce the number of blood samples needed, but their validity has been questioned. The aim of this study was to evaluate the accuracy and reliability of a classic transcutaneous bilirubinometer.

Method: Descriptive observational cross-sectional study of a sam-ple of 117 simultaneous measurements of transcutaneous and serum bilirubin in 82 jaundiced newborn infants. We analyzed the agreement between repeat measurements and measurements in different sites. We developed predictive models of serum bilirubin and analyzed their validity.

Results: All points of measurement displayed excellent agreement between repeat measures (intraclass correlation co-efficient higher than 0.92). Forehead measurements had a linear correlation coefficient of 0.75; in the sternum II-near correlation coefficient varied according to the absence or presence of phototherapy (0.86 and 0.54 respectively). The error intervals in which predictions of se-rum bilirubin were found were #+ 2 mg/dl for low values and #+ 4 mg/dl for high values (#> 15 mg/dl).

Conclusions: Reliability of the transcutaneous bilirubinometer evaluated was high, but the substantial degree of error in se-rum bilirubin make its accuracy questionable, especially in patients with high levels.

Download full-text PDF

Source

Publication Analysis

Top Keywords

serum bilirubin
8
agreement repeat
8
correlation coefficient
8
se-rum bilirubin
8
[evaluation transcutaneous
4
transcutaneous bilirubinometer]
4
bilirubinometer] objective
4
transcutaneous
4
objective transcutaneous
4
transcutaneous bilirubinometers
4

Similar Publications

For the first time, a TiCT-MXene and poly (3, 4-ethylenedioxythiophene): poly (styrenesulfonate) (PEDOT: PSS) composite-modified electrode has been developed for electrochemical detection of the bilirubin (BR) by molecularly imprinted ortho-phenylenediamine (o-PD). BR is a biomarker for liver-related diseases. High levels of BR imply liver dysfunction; hence, its exact and rapid measurement is indispensable to its immediate diagnosis and treatment.

View Article and Find Full Text PDF

Since the establishment of the COVID-19 pandemic, a range of studies have been developed to understand the pathogenesis of SARS-CoV-2 infection, vaccine development, and therapeutic testing. However, the possible impacts that these viruses can have on non-target organisms have been explored little, and our knowledge of the consequences of the COVID-19 pandemic for biota is still very limited. Thus, the current study aimed to address this knowledge gap by evaluating the possible impacts of oral exposure of C57Bl/6 J female mice to SARS-CoV-2 lysate protein (at 20 µg/L) for 30 days, using multiple methods, including behavioral assessments, biochemical analyses, and histopathological examinations.

View Article and Find Full Text PDF

Background: The link between waist-to-height ratio (WHtR) and osteoporosis (OP) remains a contentious issue in the field of medical research. Currently, the available evidence on this association is deemed insufficient. This topic has garnered significant attention and is a focal point of ongoing investigations.

View Article and Find Full Text PDF

Strategic design and development of nanomaterials-based detection platforms specific to critical biomarkers like bilirubin holds immense promise for revolutionizing early disease detection. Bilirubin (BR) plays a pivotal role as a biomarker for liver function, making accurate and timely detection of BR crucial for diagnosing and monitoring of liver diseases. In this work, we synthesized blue light emitting graphene quantum dots (GQDs) via a single step pyrolysis method, which exhibited excellent photostability and biocompatibility.

View Article and Find Full Text PDF

Background/aim: Atezolizumab plus bevacizumab (AteBev) is widely used as a first-line treatment for advanced hepatocellular carcinoma (HCC). However, evidence regarding the optimal drug sequence following AteBev treatment is limited. This study aimed to compare the treatment outcomes between tyrosine kinase inhibitors (TKIs) and durvalumab plus tremelimumab (DurTre) following AteBev treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!